MRK241108P114000
- 12.45
- 0.000.00%
Merck & Co Newsroom
Monday Market Moves Sideways, Election and FOMC in Sight | Wall Street Today
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
The U.S. Elections Will Impact the Direction of History. What Else to Watch Beyond the Presidential Race?
Monday Market Mixed Before Crazy, Pivotal Week | Live Stock
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $120 to $125
Weekly Buzz: Magnificent Mix of Market Reactions
November Starts with a Climb to end Tough Week | Wall Street Today
Merck Price Target Cut to $110.00/Share From $125.00 by Wells Fargo
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
Sector Update: Health Care Stocks Higher Friday Afternoon
Express News | BMO Capital Maintains Outperform on Merck & Co, Lowers Price Target to $136
Friday Market Climbs on Amazon Earnings, Labor Numbers at Four-Year Low | Live Stock
Merck Is Maintained at Equal-Weight by Morgan Stanley
Goldman Sachs Adjusts Merck & Co.'s Price Target to $135 From $139
Merck & Co Analyst Ratings
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $110 to $150
Today's Analyst Rating | Amazon Price Target Raised to $250 by J.P. Morgan, Meta Platforms Price Target Raised to $630 by Barclays
Express News | Merck & Co., Inc. : Morgan Stanley Cuts Target Price to $123.00 From $130.00
Merck & Co Inc (MRK) Q3 2024 Earnings Call Highlights: Strong Oncology and Animal Health ...
Thursday, Halloween Market Falls in Scary Reaction to Earnings | Wall Street Today